Giulio Vistoli
Giulio Vistoli
Email verificata su unimi.it
Titolo
Citata da
Citata da
Anno
VEGA–an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming
A Pedretti, L Villa, G Vistoli
Journal of computer-aided molecular design 18 (3), 167-173, 2004
6772004
Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A
KV Butler, J Kalin, C Brochier, G Vistoli, B Langley, AP Kozikowski
Journal of the American Chemical Society 132 (31), 10842-10846, 2010
5692010
VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs
A Pedretti, L Villa, G Vistoli
Journal of Molecular Graphics and Modelling 21 (1), 47-49, 2002
4462002
Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation
G Vistoli, D De Maddis, A Cipak, N Zarkovic, M Carini, G Aldini
Free radical research 47 (sup1), 3-27, 2013
4242013
Assessing drug-likeness–what are we missing?
G Vistoli, A Pedretti, B Testa
Drug discovery today 13 (7-8), 285-294, 2008
2142008
The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats
G Aldini, M Orioli, G Rossoni, F Savi, P Braidotti, G Vistoli, KJ Yeum, ...
Journal of cellular and molecular medicine 15 (6), 1339-1354, 2011
1472011
Reactions and enzymes in the metabolism of drugs and other xenobiotics
B Testa, A Pedretti, G Vistoli
Drug discovery today 17 (11-12), 549-560, 2012
1322012
Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products
G Aldini, G Vistoli, M Stefek, N Chondrogianni, T Grune, J Sereikaite, ...
Free radical research 47 (sup1), 93-137, 2013
1212013
N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why
G Aldini, A Altomare, G Baron, G Vistoli, M Carini, L Borsani, F Sergio
Free radical research 52 (7), 751-762, 2018
1122018
Albumin is the main nucleophilic target of human plasma: a protective role against pro-atherogenic electrophilic reactive carbonyl species?
G Aldini, G Vistoli, L Regazzoni, L Gamberoni, RM Facino, S Yamaguchi, ...
Chemical research in toxicology 21 (4), 824-835, 2008
1062008
Protein carbonylation: 2, 4-dinitrophenylhydrazine reacts with both aldehydes/ketones and sulfenic acids
I Dalle-Donne, M Carini, M Orioli, G Vistoli, L Regazzoni, G Colombo, ...
Free Radical Biology and Medicine 46 (10), 1411-1419, 2009
922009
Actin Cys374 as a nucleophilic target of α, β-unsaturated aldehydes
I Dalle-Donne, M Carini, G Vistoli, L Gamberoni, D Giustarini, R Colombo, ...
Free Radical Biology and Medicine 42 (5), 583-598, 2007
892007
Covalent modification of actin by 4‐hydroxy‐trans‐2‐nonenal (HNE): LC‐ESI‐MS/MS evidence for Cys374 Michael adduction
G Aldini, I Dalle‐Donne, G Vistoli, R Maffei Facino, M Carini
Journal of mass spectrometry 40 (7), 946-954, 2005
822005
Atom-type description language: A universal language to recognize atom types implemented in the VEGA program
A Pedretti, L Villa, G Vistoli
Theoretical Chemistry Accounts 109 (4), 229-232, 2003
802003
Identification of actin as a 15-deoxy-Δ12, 14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational, and functional approaches to investigate theá…
G Aldini, M Carini, G Vistoli, T Shibata, Y Kusano, L Gamberoni, ...
Biochemistry 46 (10), 2707-2718, 2007
792007
Analysis of the full-length integrase–DNA complex by a modified approach for DNA docking
L De Luca, A Pedretti, G Vistoli, ML Barreca, L Villa, P Monforte, A Chimirri
Biochemical and Biophysical Research Communications 310 (4), 1083-1088, 2003
702003
Bicyclic-capped histone deacetylase 6 inhibitors with improved activity in a model of axonal Charcot–Marie–Tooth disease
S Shen, V Benoy, JA Bergman, JH Kalin, M Frojuello, G Vistoli, W Haeck, ...
ACS chemical neuroscience 7 (2), 240-258, 2016
692016
Indole-2-carboxamide-based MmpL3 inhibitors show exceptional antitubercular activity in an animal model of tuberculosis infection
J Stec, OK Onajole, S Lun, H Guo, B Merenbloom, G Vistoli, WR Bishai, ...
Journal of medicinal chemistry 59 (13), 6232-6247, 2016
652016
Protein haptenation by amoxicillin: high resolution mass spectrometry analysis and identification of target proteins in serum
A Ariza, D Garzon, DR Abßnades, V de los RÝos, G Vistoli, MJ Torres, ...
Journal of proteomics 77, 504-520, 2012
652012
Design, synthesis, and evaluation of carnosine derivatives as selective and efficient sequestering agents of cytotoxic reactive carbonyl species
G Vistoli, M Orioli, A Pedretti, L Regazzoni, R Canevotti, G Negrisoli, ...
ChemMedChem 4 (6), 967-975, 2009
602009
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20